DHRS4 and nonpapillary renal cell carcinoma: Recent data suggest that DHRS4-AS1 is a tumor inhibitor in clear cell renal cell carcinoma (ccRCC), demonstrating that DHRS4-AS1 is a potential prognostic biomarker in ccRCC (32).